Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While PEG-MGF is used experimentally to enhance muscle repair and hypertrophy after mechanical overload or injury by stimulating satellite-cell activation and protein synthesis6373138, Sermorelin is used as a diagnostic agent for assessing GH secretory capacity and as a research tool or off-label therapy to increase endogenous GH in GH-deficient or age-related contexts1727.
While PEG-MGF works as a poly(ethylene glycol)-conjugated form of Mechano Growth Factor (IGF-1Ec splice variant) comprising the 24-aa C-terminal E-peptide of IGF-1, designed to extend half-life while activating IGF-1 receptor–mediated anabolic signaling in muscle satellite cells637322138, Sermorelin is a synthetic 29-amino-acid peptide identical to the 1–29 N-terminal fragment of human GHRH that stimulates GH synthesis and secretion by binding pituitary GHRH receptors1727120.
PEG-MGF
IGF1
Sermorelin
GHRH
PEG-MGF and Sermorelin are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: PEG-MGF is more often discussed in the realm of Musculoskeletal health and Cardiovascular health, whereas Sermorelin is more often associated with the realm of Metabolic and endocrine and Aging and longevity. Their biological logic is quite different: PEG-MGF is a growth factor mimetic and a signaling modulator, whereas Sermorelin is a receptor agonist. Both are synthetic in origin and their development context also differs, with PEG-MGF in Preclinical development while Sermorelin is approved. PEG-MGF takes the form of a peptide conjugate, whereas Sermorelin is closer to a linear peptide, PEG-MGF carries pegylation features, while Sermorelin instead reflects amidation changes; while their sequence patterns also diverge, with PEG-MGF showing protein-mimetic sequence features and Sermorelin showing alpha-helical domain features.
No related articles are linked to these peptides yet.